A new playground is open at Pleasants Lane Elementary progress-index.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from progress-index.com Daily Mail and Mail on Sunday newspapers.
AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia May 4, 2021
Investment will triple local employment and strengthen regional pharma industry
Furthers SK Group’s plans to invest in and grow U.S. businesses
AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25 million in its Petersburg, Va., site as part of a commitment to bring high-quality pharmaceutical manufacturing to the U.S.
In addition to the new jobs, AFC will expand the site’s capabilities by adding an East Coast presence for AMPAC Analytical Labs and enhanced R&D functions for continuous processing of pharmaceutical ingredients. AMPAC Analytical provides extensive development and testing services for the analysis, validation and release of intermediates and APIs
Ampac announces $25m expansion of pharma facility outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients.
Jan 30th, 2021
Civica Rx (Civica, Inc.) announced, along with Virginia’s Governor Ralph Northam, its plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia, potentially creating more than 180 jobs. The new plant represents a $124.5 million investment.
Building its own state-of-the-art manufacturing operation in the United States has been a part of Civica’s supply strategy since it was founded by leading health systems and philanthropies in late 2018 to address drug shortages and ensure a resilient supply of quality medicines at affordable prices for U.S. patients.